Join Galaxy Australia to view the ELIXIR-Galaxy webinar in our timezone and have your questions answered live by the speakers. You’ll be introduced to the Galaxy platform and other public research infrastructure by world leaders in the field. You’ll hear about the motivation behind the Galaxy COVID-19 projects and the benefits of open reproducible research and transparent and interoperable analytics.
Webinar speakers:
Anton Nekrutenko, Professor of Biochemistry and Molecular Biology at Penn State University (USA) and co-founder of the Galaxy Project.
Sergei Pond, Professor of Biology, Institute for Genomics and Evolutionary Medicine, Temple University, US
Frederik Coppens, Head of Node of ELIXIR Belgium and Co-Lead of the ELIXIR Galaxy Community
Björn Grüning, Technical Coordinator of ELIXIR Germany and Co-Lead of the ELIXIR Galaxy Community
Live Q&A
Frederik and Björn will be available afterward to answer all of your questions, along with Galaxy Australia staff who can assist you in accessing resources straight away.
Researchers from universities in Germany, Belgium, Australia and the USA recently used publicly available novel coronavirus (COVID-19) genome data and published their analyses using Galaxy, demonstrating how the COVID-19 genome data can be shared, analysed and reproduced in an efficient and transparent way. More information about the publication here.
Galaxy Australia contributed to the development of the SARS-CoV-2 data analyses workflows and Australian researchers can now access these resources on the dedicated Galaxy COVID-19 compute node hosted at Pawsey Supercomputing Centre. More details on the Galaxy Australia Pawsey node here.
The Galaxy-ELIXIR webinar series brings together experts from ELIXIR and the international Galaxy community will guide participants step-by-step through setting up and executing the SARS-CoV-2 data analyses workflows developed by the global Galaxy community. After completing the series, participants will be able to fully reproduce the workflows and conduct their own analyses of SARS-CoV-2 data. More information on the Galaxy-ELIXIR series here (including recordings of past sessions).
*Note this 2 June event will replay the first webinar from the series, as seen in the UK on 1 May. The viewing will be accompanied by a live Q&A session.